Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
- PMID: 18181532
- PMCID: PMC2750697
- DOI: 10.1208/pt0804111
Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
Abstract
The purpose of the present research was to investigate the mechanism for improved intercellular and intracellular drug delivery from ethosomes using visualization techniques and cell line study. Ethosomal formulations were prepared using lamivudine as model drug and characterized in vitro, ex vivo and in vivo. Transmission electron microscopy, scanning electron microscopy, and fluorescence microscopy were employed to determine the effect of ethosome on ultrastructure of skin. Cytotoxicity and cellular uptake of ethosome were determined using T-lymphoid cell line (MT-2). The optimized ethosomal formulation showed 25 times higher transdermal flux (68.4 +/- 3.5 microg/cm(2)/h) across the rat skin as compared with that of lamivudine solution (2.8 +/- 0.2 microg/cm(2)/h). Microscopic studies revealed that ethosomes influenced the ultrastructure of stratum corneum. Distinct regions with lamellar stacks derived from vesicles were observed in intercellular region of deeper skin layers. Results of cellular uptake study showed significantly higher intracellular uptake of ethosomes (85.7% +/- 4.5%) as compared with drug solution (24.9% +/- 1.9%). The results of the characterization studies indicate that lipid perturbation along with elasticity of ethosomes vesicles seems to be the main contributor for improved skin permeation.
Similar articles
-
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16. J Control Release. 2007. PMID: 17884226
-
Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.Eur J Pharm Biopharm. 2007 Sep;67(2):398-405. doi: 10.1016/j.ejpb.2007.03.007. Epub 2007 Mar 14. Eur J Pharm Biopharm. 2007. PMID: 17452098
-
Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.Anesth Analg. 2013 Aug;117(2):352-7. doi: 10.1213/ANE.0b013e3182937b74. Epub 2013 Jun 6. Anesth Analg. 2013. PMID: 23744957
-
Liposomes and skin: from drug delivery to model membranes.Eur J Pharm Sci. 2008 Aug 7;34(4-5):203-22. doi: 10.1016/j.ejps.2008.05.002. Epub 2008 May 8. Eur J Pharm Sci. 2008. PMID: 18572392 Review.
-
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.Int J Pharm. 2007 Mar 6;332(1-2):1-16. doi: 10.1016/j.ijpharm.2006.12.005. Epub 2006 Dec 8. Int J Pharm. 2007. PMID: 17222523 Review.
Cited by
-
Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.J Control Release. 2014 Jan 10;173:67-74. doi: 10.1016/j.jconrel.2013.10.007. Epub 2013 Oct 12. J Control Release. 2014. PMID: 24129342 Free PMC article.
-
Propellant Free Pressurized Spray System of Etodolac to Manage Acute Pain Conditions: In Vitro and In Vivo Evaluation.AAPS PharmSciTech. 2024 May 14;25(5):112. doi: 10.1208/s12249-024-02807-9. AAPS PharmSciTech. 2024. PMID: 38744715
-
Formulation and Characterization of Ethosomes for Transdermal Delivery of Prinsepia Utilis Rogle Seed Oil with Ameliorative Effects against UVB-Induced Skin Damage.AAPS PharmSciTech. 2024 May 30;25(5):122. doi: 10.1208/s12249-024-02822-w. AAPS PharmSciTech. 2024. PMID: 38816546
-
Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.Int J Nanomedicine. 2015 Sep 18;10:5837-51. doi: 10.2147/IJN.S86186. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26425085 Free PMC article.
-
Design and Characterization of Ethosomes for Transdermal Delivery of Caffeic Acid.Pharmaceutics. 2020 Aug 6;12(8):740. doi: 10.3390/pharmaceutics12080740. Pharmaceutics. 2020. PMID: 32781717 Free PMC article.
References
-
- Dutta T, Jain NK. Targeting potential and anti-HIV activity of lamivudine-loaded mannosylated poly(propyleneimine) dendrimer. Biochim Biophys Acta. 2007;1770:681–686. - PubMed
-
- Schreier H, Bouwstra J. Liposomes and niosomes as a drug carriers: dermal and transdermal drug delivery. J Control Release. 1994;30:1–15. doi: 10.1016/0168-3659(94)90039-6. - DOI
-
- Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A. The skin: a pathway for the systemic treatment with patches and lipid based agent carriers. Adv Drug Deliv Rev. 1996;18:349–378. doi: 10.1016/0169-409X(95)00091-K. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources